Exposure to pioglitazone and the risk of prostate cancer: a nested case-control study

First published 13/04/2016

Last updated 25/03/2024

EU PAS number:

EUPAS11750

Study

Finalised

Download as PDF

Documents

Study protocol

Study results

Study results

Abstract Pioglitazone_5018_Redacted

English (615.2 KB - PDF)View document

Study report

Other information

ENCePP Seal

ENCePP Seal documents